The Effects of Board Game in Learning Medication Knowledge Among Nursing Students

March 1, 2021 updated by: Taipei Medical University

Background: Maintaining patient safety is one of the primary tasks of a professional nurse. Correct identification of medicine, understanding of pharmacological mechanisms and side effects are the basic academic knowledge that each nurse must possess. Therefore, it is an important duty for nursing teachers to teach students the knowledge of drugs and use them correctly in clinical practice. In this way, the safety of patients can be guaranteed and the quality of care can be improved. Board games have been used for study in different subjects, and they all have visible effects. Their competitive and entertaining qualities make learning more interesting and allow students to learn in a pleasant atmosphere. Therefore, the purpose of this study is to examine the effectiveness of using board games to teach medication knowledge to nursing students.

Methodology: This is a randomized controlled trial study. Convenience sampling will be applied in one university in Northern Taiwan.It is expected that 60-100 participants will be recruited and randomly assigned to the experimental group and comparison group by computer. The experimental group will use board game to learn medication, while the comparison group will be taught in a traditional way. The questionnaires will be conducted before the intervention, after the intervention, and one month later. The time for completing questionnaire is about 5~15 minutes. The questionnaires include demographic information, medication knowledge questionnaire, and learning satisfaction questionnaire. This study will use SPSS 22.0 software for data analysis, including frequency, percentage, mean, standard deviation, t-test, chi-square, and generalized estimation equation (GEE).

Expected results: This study will be able to understand the effects of board games in learning medication among nursing students.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei city, Taiwan, 10675
        • Taipei Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Nursing student The student who has not yet taken a practicum course

Exclusion Criteria:

The student who had already taken a pharmacology course or is taking a pharmacology course.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
The students in this group will learn medication knowledge by using board game.
The students in the experimental group will play board game to learn medication about 30-60 minutes.
Active Comparator: Comparison group
The students in this group will learn medication knowledge through tradition lecture.
The students in the comparison group will receive medication lecture using PPT slides about 30-60 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Medication knowledge at 1 month
Time Frame: The data will be collected at baseline,immediately after the intervention, and one month after the intervention.
This self-developed questionnaire which was validated by 5 experts will be used to understand students' medication knowledge level. The questionnaire includes 20 questions, 1 point for correct answers, 0 points for incorrect answers or not knowing, the total score is between 0 and 20 points, the higher the score represent the higher understanding of medical knowledge.
The data will be collected at baseline,immediately after the intervention, and one month after the intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Learning satisfaction questionnaire
Time Frame: The data will be collected immediately after the intervention.
This self-developed questionnaire which was validated by 5 experts will be used to understand students' sanctification level regarding learning through board game or traditional lecture.The questionnaire consists of 8 questions. It is scored using the Likert scale 5 points method. 1 point is strongly disagreeable, 2 points are disagreeable. 3 points are generally agreed. 4 points are agreed. The total score is between 8-40 points, a higher score indicates that the student is more satisfied with the teaching method.
The data will be collected immediately after the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yeu-Hui Chuang, PhD, Taipei Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2020

Primary Completion (Actual)

December 29, 2020

Study Completion (Actual)

February 28, 2021

Study Registration Dates

First Submitted

January 12, 2020

First Submitted That Met QC Criteria

January 19, 2020

First Posted (Actual)

January 22, 2020

Study Record Updates

Last Update Posted (Actual)

March 3, 2021

Last Update Submitted That Met QC Criteria

March 1, 2021

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • N201912063

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Every information of the participants are classified, only the result of the research can be accessed to.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knowledge

Clinical Trials on Board game

Subscribe